Intuitive Surgical price target lowered to $305 from $318 at Citi

Citi analyst Joanne Wuensch lowered the firm’s price target on Intuitive Surgical to $305 from $318 and keeps a Buy rating on the shares post the Q4 results. The quarter was negatively impacted by the resurgence of COVID-19 in China, as well as currency and consumer buying patterns, the analyst tells investors in a research note. The firm says that while Intuitive has no new multi-port robot in 2023, it is seeing lots of procedural demand.